Alzheimer?s disease (AD) is the most common cause of cognitive impairment in older adults and affects over 5 million people in the US alone. Individuals who carry the apolipoprotein E-?4 (APOE4) gene are at heightened risk for developing late onset AD while individuals with the presenilin 1 (PSEN1) gene mutation will develop autosomal-dominant AD. Project 2 of the proposed P01 ?Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer?s Disease? will provide critical advances towards discovering how changes in brain connectivity, structure and function relate to neurovascular integrity and ultimately confer cognitive impairment in AD genetic risk groups. Across 5 sites, Project 2 will recruit 722 participants, including 294 APOE4 carriers and 340 non-carriers, and 44 PSEN1 mutation carriers and 44 non-carriers, followed longitudinally to evaluate changes in brain structure and function. Participants with NCI or early MCI will receive our imaging protocol every 2 years: 1) multi-shell DTI for white matter network connectivity; 2) resting fMRI for functional network connectivity; 3) structural MRI for gray matter shape, volume; and 4) DCE-MRI, ASL perfusion (from Project 1); in addition to Uniform Data Sets (UDS) cognitive tests. 150 participants (50 APOE4 carriers, 100 non-carriers) will also complete an amyloid PET scan to examine the effect of amyloid deposition on brain function and structure. We will address aims directed at assessing differences in structural and functional connectivity, examining the temporal association between brain connectivity changes over time, understanding how brain connectivity predicts future cognitive decline, and evaluating how blood-brain barrier integrity impacts brain connectivity. The relationship between structural connectivity, functional connectivity, and neurovascular integrity has not been explored. Using advanced neuroimaging methodology, this project will apply a hypothesis-driven approach to understand how brain structure and function change in individuals with high genetic risk for AD, and the impact of neurovascular integrity on these changes.
| Ho, Jean K; Nation, Daniel A; Alzheimer’s Disease Neuroimaging Initiative (2018) Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease. J Int Neuropsychol Soc 24:693-702 |
| Weissberger, Gali H; Nation, Daniel A; Nguyen, Caroline P et al. (2018) Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans. Neurosci Biobehav Rev 94:49-58 |
| Sinha, Ranjeet K; Wang, Yaoming; Zhao, Zhen et al. (2018) PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. Blood 131:1163-1171 |
| Nation, Daniel A; Tan, Alick; Dutt, Shubir et al. (2018) Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion. J Alzheimers Dis 61:91-101 |
| Sweeney, Melanie D; Kisler, Kassandra; Montagne, Axel et al. (2018) The role of brain vasculature in neurodegenerative disorders. Nat Neurosci 21:1318-1331 |
| Nation, Daniel A (2018) Blood Pressure and Cerebral Blood Flow in Alzheimer Disease. Hypertension 72:68-69 |
| Netto, Joao Prola; Iliff, Jeffrey; Stanimirovic, Danica et al. (2018) Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol. Neurosurgery 82:770-780 |
| Montagne, Axel; Nikolakopoulou, Angeliki M; Zhao, Zhen et al. (2018) Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med 24:326-337 |
| Sweeney, Melanie D; Zlokovic, Berislav V (2018) A lymphatic waste-disposal system implicated in Alzheimer's disease. Nature 560:172-174 |
| Li, Junning; Gahm, Jin Kyu; Shi, Yonggang et al. (2018) Topological false discovery rates for brain mapping based on signal height. Neuroimage 167:478-487 |
Showing the most recent 10 out of 29 publications
